These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8031820)

  • 1. Cytomegalovirus infection and the development of cellular rejection.
    Fyfe AI
    J Heart Lung Transplant; 1994; 13(2):343. PubMed ID: 8031820
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus induces class II expression in rat heart endothelial cells.
    Ustinov JA; Loginov RJ; Bruggeman CA; van der Meide PH; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(4):644-51. PubMed ID: 8396436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of human vascular endothelial cells with cytomegalovirus: effects on the expression of human leukocyte antigens.
    Scholz M; Blaheta RA; Hamann A; Encke A; Markus BH
    Transplant Proc; 1992 Dec; 24(6):2565-6. PubMed ID: 1334585
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial interleukin-6 blood levels early after cardiac transplantation.
    Weyand M; Krehmeier M; Fahrenkamp A; Middendorf C; Redmann M; Schwartz C; Konertz W; Scheld HH
    Transplant Proc; 1992 Dec; 24(6):2546. PubMed ID: 1334584
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology.
    Arkonac B; Mauck KA; Chou S; Hosenpud JD
    J Heart Lung Transplant; 1997 Oct; 16(10):1035-45. PubMed ID: 9361246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular endothelium as target of humoral auto-reactivity in myocarditis and rejection.
    Maisch B; Weyerer O; Hufnagel G; Hengstenberg C; Schönian U; Haverich A; Kochsiek K
    Z Kardiol; 1989; 78 Suppl 6():95-9. PubMed ID: 2694667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus surveillance following liver transplantation: does it allow presymptomatic diagnosis of cytomegalovirus disease?
    Umana JP; Mutimer DJ; Shaw JC; McLeish PJ; Buchan A; Martin B; Neuberger JM; Elias E; McMaster P
    Transplant Proc; 1992 Dec; 24(6):2643-5. PubMed ID: 1334593
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus infection in liver transplantation: graft infection and clinical relevance.
    Sido B; Hofmann WJ; Otto G; Amann K; Arnold JC; Herfarth C
    Transplant Proc; 1992 Dec; 24(6):2641-2. PubMed ID: 1334592
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated responses to donor endothelium: concerning the concern.
    Hosenpud JD
    J Heart Lung Transplant; 1997 Jun; 16(6):687. PubMed ID: 9229302
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytomegalovirus and immunomodulation].
    Charpentier B
    Nephrologie; 1988; 9(4):163-5. PubMed ID: 2851112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
    Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells.
    Tuder RM; Weinberg A; Panajotopoulos N; Kalil J
    J Heart Lung Transplant; 1994; 13(1 Pt 1):129-38. PubMed ID: 8167118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis.
    Pandey JP; LeRoy EC
    Arthritis Rheum; 1998 Jan; 41(1):10-5. PubMed ID: 9433864
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytomegalovirus enhances PBMC binding and HLA class I expression on cultured endothelial cells.
    Tuder RM; Weinberg A; Panajotopoulos N; Kalil J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):91-2. PubMed ID: 1846720
    [No Abstract]   [Full Text] [Related]  

  • 19. Class II major histocompatibility complex antigens on cardiac endothelium: an early biopsy marker of rejection in the transplanted human heart.
    Caforio AL; Bottazzo GF; McKenna WJ; Counihan PJ; Burke M; Poloniecki J; Davies MJ; Pepper JR
    Transplant Proc; 1990 Aug; 22(4):1830-3. PubMed ID: 2202130
    [No Abstract]   [Full Text] [Related]  

  • 20. Th1 adaptive immune responses in cardiac graft arteriosclerosis: deleterious or beneficial?
    Tellides G
    Circulation; 2006 Oct; 114(15):1561-4. PubMed ID: 17030702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.